Stockreport

Organon and Cirqle Biomedical Enter Research Collaboration and License Agreement for Investigational Non-hormonal, On-demand Contraceptive Candidate

Organon & Co.  (OGN) 
PDF Collaboration continues to expand portfolio in women’s health to help address unmet needs JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), a global women’s he [Read more]